2.79
-0.0958(-3.31%)
Currency In USD
| Previous Close | 2.89 |
| Open | 2.86 |
| Day High | 2.86 |
| Day Low | 2.64 |
| 52-Week High | 6.01 |
| 52-Week Low | 1.1 |
| Volume | 816,738 |
| Average Volume | 276,045 |
| Market Cap | 54.5M |
| PE | -1.43 |
| EPS | -1.96 |
| Moving Average 50 Days | 3.06 |
| Moving Average 200 Days | 2.4 |
| Change | -0.1 |
If you invested $1000 in NRx Pharmaceuticals, Inc. (NRXP) since IPO date, it would be worth $29.17 as of August 18, 2025 at a share price of $2.8. Whereas If you bought $1000 worth of NRx Pharmaceuticals, Inc. (NRXP) shares 5 years ago, it would be worth $26.07 as of August 18, 2025 at a share price of $2.8.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire Inc.
7 hours ago
NRx Drug Development Grant of expanded Fast Track Designation for NRX-100 from the FDA for all indications and types of depression and related disorders based on its potential to satisfy an unmet medical need.Represents an approximately 10-fold expan
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024
GlobeNewswire Inc.
Oct 23, 2024 12:30 PM GMT
MIAMI, Oct. 23, 2024 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, (“NRx,” the “Company”) and HOPE Therapeutics, Inc., a medical and technology driven company and wholly-owned subsidiary o